Hikma Pharmaceuticals (HIK) News Today GBX 1,932 +2.00 (+0.10%) As of 08:34 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityBuy This Stock HIK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Another $122M from opioid settlements now available to WashingtonJuly 29, 2025 | yahoo.comHikma Pharmaceuticals Donates $1.1 Million in Medical Aid to SyriaJuly 24, 2025 | msn.comHikma Pharmaceuticals (LON:HIK) shareholders have earned a 8.3% CAGR over the last three yearsJuly 23, 2025 | finance.yahoo.comHikma Pharmaceuticals PLC (HIK) Stock Price Today - WSJJuly 15, 2025 | wsj.comHikma Pharmaceuticals slips Friday, underperforms marketJuly 11, 2025 | marketwatch.comNew Hampshire to receive $4.5 million as part of nationwide opioid settlementsJuly 11, 2025 | msn.comDrug maker Hikma announces $1 billion expansion, including its West Side Columbus plantJuly 2, 2025 | msn.comHikma Pharmaceuticals plans USD1 billion investment to support US unitJune 30, 2025 | lse.co.ukCentral Ohio's second-largest manufacturer plans $1B U.S. expansionJune 30, 2025 | bizjournals.comHikma Pharmaceuticals to invest $1B by 2030 to expand US manufacturing, R&DJune 30, 2025 | msn.comHikma Pharmaceuticals (LON:HIK) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?June 19, 2025 | marketbeat.comHikma Pharmaceuticals rallies Thursday, outperforms marketJune 12, 2025 | marketwatch.comHikma Pharmaceuticals (LON:HIK) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?June 11, 2025 | marketbeat.comDIRECTOR DEALINGS: Hikma exec and AB Dynamics advisor sell sharesJune 10, 2025 | lse.co.ukHikma Pharmaceuticals PLC (LON:HIK) Insider Sells £296,390.94 in StockJune 4, 2025 | insidertrades.comInsider Selling: Hikma Pharmaceuticals PLC (LON:HIK) Insider Sells 13,863 Shares of StockJune 3, 2025 | marketbeat.comHikma Pharmaceuticals (LON:HIK) Share Price Crosses Above Two Hundred Day Moving Average - What's Next?June 3, 2025 | marketbeat.comHikma Pharmaceuticals advances Wednesday, outperforms marketMay 28, 2025 | marketwatch.comGrowth is what results from strategy. Luckily, this firm has a planMay 27, 2025 | finance.yahoo.comReshaped Combogesic deal sets 'pleased' AFT Pharma up to answer US demandMay 26, 2025 | msn.comHikma Pharmaceuticals (LON:HIK) Share Price Passes Above 200-Day Moving Average - Should You Sell?May 26, 2025 | marketbeat.comHikma Pharmaceuticals (LON:HIK) Trading Up 7.4% - Still a Buy?May 18, 2025 | marketbeat.comFTSE 100 battles higher as defensive stocks sought, Aviva and Hikma make splashMay 16, 2025 | uk.investing.comU.K. stocks rise for first time in two daysMay 15, 2025 | marketwatch.comHikma shares climb on new outlook, targets USD5 billion sales by 2030May 15, 2025 | lse.co.ukEuropean stocks rise as US and China agree to slash tariffsMay 12, 2025 | msn.comS&P upgrades Hikma Pharmaceuticals PLC, senior notes to ‘BBB’May 12, 2025 | msn.comHikma Pharmaceuticals gets ’BBB’ rating upgrade from S&P on strong momentumMay 8, 2025 | investing.comHikma Pharma to pay $50 million to settle narcolepsy drug antitrust caseMay 8, 2025 | msn.comHealthcare and consumer gains propel UK shares higherApril 28, 2025 | msn.comHikma Pharmaceuticals advances Monday, outperforms marketApril 28, 2025 | marketwatch.comHikma shares edge up on steady guidanceApril 24, 2025 | uk.investing.comHikma reiterates full year guidance following good start to the yearApril 24, 2025 | msn.comIs this FTSE 100 share a screaming buy to consider after recent falls?April 22, 2025 | msn.comInsider Selling: Hikma Pharmaceuticals PLC (LON:HIK) Insider Sells 2,777 Shares of StockApril 10, 2025 | marketbeat.comLONDON BROKER RATINGS: Jefferies raises Hikma Pharmaceutical to 'buy'April 10, 2025 | lse.co.ukHikma signs licensing agreement to bring innovative oncology treatment to MENAApril 9, 2025 | msn.comHikma Pharmaceuticals slips Wednesday, underperforms marketApril 9, 2025 | marketwatch.comFTSE 100 Live 09 April: Oil and pharma stocks retreat as heavy selling resumesApril 9, 2025 | msn.comHikma signs exclusive licensing agreement to bring innovative oncology treatment to MENAApril 9, 2025 | msn.comHikma Pharmaceuticals PLC (LON:HIK) Insider Sells £49,986 in StockApril 9, 2025 | insidertrades.comAn Idaho warden acquired lethal injection drugs from an undisclosed supplier on a rural roadApril 5, 2025 | msn.comThe top British companies to see a share price drop on the back of Trump's tariffsApril 4, 2025 | msn.comFTSE 100 Live 02 April: Tariff fears hit blue-chip stocks, Raspberry Pi shares surgeApril 2, 2025 | msn.comFTSE 100 Live 02 April: Tariff fears hit blue-chip stocks , Raspberry Pi shares surgeApril 2, 2025 | msn.comHikma Pharmaceuticals (LON:HIK) Share Price Passes Above 200 Day Moving Average - Should You Sell?March 26, 2025 | marketbeat.comHikma Pharmaceuticals announces Health Canada approval of KLOXXADO nasal sprayMarch 20, 2025 | markets.businessinsider.comHikma Pharmaceuticals PLC (LON:HIK) Increases Dividend to $0.48 Per ShareMarch 19, 2025 | marketbeat.comShould Income Investors Look At Hikma Pharmaceuticals PLC (LON:HIK) Before Its Ex-Dividend?March 16, 2025 | finance.yahoo.comHikma Pharmaceuticals slips Thursday, underperforms marketMarch 13, 2025 | marketwatch.com Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HIK and its competitors with MarketBeat's FREE daily newsletter. Email Address HIK Media Mentions By Week HIK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HIK News Sentiment▼0.000.46▲Average Medical News Sentiment HIK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HIK Articles This Week▼02▲HIK Articles Average Week Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HIK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HUTCHMED News Indivior News Allergy Therapeutics News Alliance Pharma News Animalcare Group News Venture Life Group News ECO Animal Health Group News Shield Therapeutics News Celadon Pharmaceuticals News Haleon News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:HIK) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWall Street Hates This Gold IRA Strategy—Here’s WhyWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
